-
Posted by
Two Blokes Jul 8 -
Filed in
Stock
-
5 views
Veeva Systems is executing strongly, with accelerating growth in Vault CRM migrations and robust momentum across its portfolio, supporting my continued buy rating. Crossix is a standout growth driver, expanding rapidly and delivering measurable ROI for customers, making it a high-priority investment for pharma clients. Veeva's targeted AI strategy, embedding AI agents into core workflows, positions the company for deeper integration and future monetization opportunities.
